Cargando…
Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight BRCA1 variants of uncertain significance by integrating available functional data with protein interaction assays
The clinical screening of cancer predisposition genes has led to the identification of a large number of variants of uncertain significance (VUS). Multifactorial likelihood models that predict the odds ratio for VUS in favor or against cancer causality, have been developed, but their use is limited...
Autores principales: | Caleca, Laura, Radice, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164951/ https://www.ncbi.nlm.nih.gov/pubmed/37168384 http://dx.doi.org/10.3389/fonc.2023.1146604 |
Ejemplares similares
-
Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria
por: Nykamp, Keith, et al.
Publicado: (2017) -
Correction: Sherloc: a comprehensive refinement of the ACMG–AMP
variant classification criteria
por: Nykamp, Keith, et al.
Publicado: (2019) -
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework
por: Brnich, Sarah E., et al.
Publicado: (2019) -
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay
por: Hu, Chunling, et al.
Publicado: (2022) -
Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
por: Savige, Judy, et al.
Publicado: (2021)